Bleakley Financial Group »

Kalvista Pharmaceuticals shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $258k 16k 16.15

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Ishares Core Msci Emkt (IEMG)

View all positions for Bleakley Financial Group

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
Woodline Partners
State Street Corporation
Vestal Point Capital
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals